Stocks
AtriCure (ATRC) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 819.0% | 497.3% | 339.7% | 176.0% | 703.4% | ||||
| Changes by years, y/y, % | +481pp | -322pp | -497pp | -164pp | -20.6% | ||||
AtriCure. R&D/CAPEX, %
AtriCure. R&D/CAPEX, changes, pp
AtriCure (ATRC) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 560.7% | 746.4% | 715.4% | 824.5% | 580.9% | 703.4% | ||
| Changes by years, y/y, % | +266pp | +417pp | +103pp | +772pp | +20pp | |||
| Changes by quarters, q/q, % | +508pp | +186pp | -31pp | +109pp | -244pp | |||
